Author

Csaba Papp

University of SzegedORCID 0000-0003-4450-0667Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Attila FarkasiD· 2 shared Ana‐Maria Pilbat· 1 shared Andras Zoltan Vonyo· 1 shared Andreea DarabaiD· 1 shared Áron SomogyiiD· 1 shared Attila GácseriD· 1 shared Balázs KrisztiD· 1 shared Balázs PappiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Attila FarkasORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivPreprintJul 21, 2026

A preclinical resistance framework discovers the virulence risks of antibiotics in development

Petra Éva Szili, Márton Simon Czikkely, Zoltan J. Farkas…·Csaba Pál

The paper develops a framework to assess antibiotic resistance and virulence risks in pathogens, finding that resistance can increase virulence through genetic changes.

DOI 10.64898/2026.07.20.739514

mousebulk RNA-seq

𝕏 PostBluesky

MicrobiologyMicrobiology SpectrumPeer-reviewedNov 19, 2024

The Neosartorya (Aspergillus) fischeri antifungal protein NFAP2 has low potential to trigger resistance development in Candida albicans in vitro

Gábor Bende, Nóra Zsindely, Krisztián Laczi…·László Galgóczy

This study shows that C. albicans develops resistance to NFAP2 with fewer genetic changes and less phenotypic impact than to fluconazole, suggesting NFAP2 is a promising antifungal with low resistance potential.

6 citations

humanexperimental assay

𝕏 PostBluesky